Beyond The Red Eye: Rational Clinical Management And Antibiotic Stewardship In Pediatric Acute Bacterial Conjunctivitis At Primary Care Level
DOI:
https://doi.org/10.31004/koloni.v5i2.907Keywords:
acute bacterial conjunctivitis, antibiotic stewardship, ocular infection, pediatric, primary care, red eyeAbstract
Acute bacterial conjunctivitis is one of the most common ocular conditions encountered in pediatric primary healthcare services. The disease is characterized by inflammation of the conjunctiva caused by bacterial infection and may lead to discomfort, temporary visual disturbance, and increased transmission risk among household contacts and school-aged children. Although many cases are self-limiting, prompt diagnosis and appropriate management remain important to accelerate clinical recovery and reduce unnecessary antibiotic exposure. This paper aims to discuss the clinical presentation, diagnosis, management, and follow-up outcomes of pediatric acute bacterial conjunctivitis in a community health center while emphasizing the importance of antibiotic stewardship in primary care practice. Clinically, bacterial conjunctivitis commonly presents with conjunctival hyperemia, mucopurulent discharge, eyelid sticking upon waking, and mild ocular irritation. Diagnosis is primarily established through history taking and ophthalmologic examination, including visual acuity assessment and anterior segment evaluation to exclude corneal involvement or other serious ocular conditions. Management includes topical antibiotic therapy, hygiene education, and monitoring for clinical improvement. In this case, significant improvement was observed after treatment, demonstrated by resolution of conjunctival injection and disappearance of ocular discharge during follow-up evaluation. Early clinical recognition and rational antibiotic use are essential to optimize patient outcomes while minimizing antimicrobial resistance in primary healthcare settings.References
American Academy of Ophthalmology, 2022. Basic and Clinical Science Course: External Disease and Cornea. San Francisco: AAO.
Drugs for Some Common Eye Disorders, 2020. JAMA, 323(5), pp.470–471. DOI: 10.1001/jama.2019.20663.
Johnson, D., Liu, D. and Simel, D., 2022. Does This Patient With Acute Infectious Conjunctivitis Have a Bacterial Infection? JAMA, 327(22), pp.2231–2237. DOI:10.1001/jama.2022.7687.
Mahoney, M.J., Bekibele, R., Notermann, S.L., Reuter, T.G. and Borman-Shoap, E.C., 2023. Pediatric Conjunctivitis: A Review of Clinical Manifestations, Diagnosis, and Management. Children, 10(5), p.808. DOI:10.3390/children10050808.
Shekhawat, N.S. et al., 2021. Antibiotic resistance patterns in pediatric conjunctivitis. Pediatrics, 147(2), p.e20193578.
World Health Organization, 2023. WHO Model List of Essential Medicines – 23rd List. Geneva: WHO.
Rahayu, T. et al., 2023. Availability and utilization of essential eye medicines in Indonesian primary healthcare. Journal of Primary Care & Community Health, 14, pp.1–9.
Pratama, R.W. and Dewi, A.I., 2022. Evaluation of antibiotic prescribing for conjunctivitis in Indonesian public health centers. Indonesian Journal of Pharmacy, 33(2), pp.150–157.
Yeu, E. and Hauswirth, S., 2020. Management strategies for infectious conjunctivitis in primary care. Clinical Ophthalmology, 14, pp.2371–2381.
Bruschi, G. et al., 2023. Vernal Keratoconjunctivitis: A Systematic Review. Clinical Reviews in Allergy & Immunology, 65, pp.277–329.
Kementerian Kesehatan Republik Indonesia, 2021. Pedoman Pelayanan Kesehatan Mata di Tingkat Primer. Jakarta: Kemenkes RI.
American Optometric Association, 2022. Clinical Practice Guideline for Conjunctivitis. St Louis: AOA.
Centers for Disease Control and Prevention, 2024. Conjunctivitis (Pink Eye): Clinical Overview. Atlanta: CDC.
American Academy of Pediatrics, 2021. Red Eye and Conjunctivitis in Children. Illinois: AAP.
European Society of Ophthalmology, 2023. Guidelines on Ocular Surface Infection Management. Brussels: SOE.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Lalu Hermawan Ranova

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
